RHEACELL GmbH & Co. KG
- Biotech or pharma, therapeutic R&D
RHEACELL, a clinical stage biopharmaceutical stem cell company based in Heidelberg, Germany.
RHEACELL is actively seeking worldwide commercial partners for our highly differentiated, systemic therapy, EBESANAR. This innovative treatment is currently in a pivotal Phase 3 trial in the US and Europe for recessive dystrophic epidermolysis bullosa (RDEB), a rare and devastating orphan disease, with top-line results anticipated in Q1 2026.
NO SERVICE PROVIDERS, THANKS!
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}